HYPERION DEFI, INC. Adjustments to Additional Paid in Capital, Warrant Issued
HYPERION DEFI, INC. (HYPD) reported Adjustments to Additional Paid in Capital, Warrant Issued of $858.27 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-13
- HYPERION DEFI, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-12-31 was -$335.83K.
- HYPERION DEFI, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- HYPERION DEFI, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-06-30 was $858.27K.
- HYPERION DEFI, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-03-31 was $1.19M.
- HYPERION DEFI, INC. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $858.27K, a 70.07% decline from fiscal 2024.
- HYPERION DEFI, INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $2.87M, a 64.95% increase from fiscal 2023.
- HYPERION DEFI, INC. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $1.74M.
- HYPERION DEFI, INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $351.39K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$335.83K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$335.83K derived: sum of 2 quarters · filed 2026-03-30 | $522.44K derived: sum of 3 quarters · filed 2026-08-13 | $858.27K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $858.27K derived: sum of 2 quarters · filed 2026-08-13 | $1.19M 10-Q · filed 2025-11-14 | $2.05M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $858.27K 10-Q · filed 2026-08-13 | $1.19M 10-Q · filed 2025-08-13 | $2.05M derived: sum of 3 quarters · filed 2026-08-13 | $4.92M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.19M 10-Q · filed 2026-08-13 | $1.19M derived: sum of 2 quarters · filed 2026-08-13 | $4.06M derived: sum of 3 quarters · filed 2026-08-13 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.87M derived: sum of 2 quarters · filed 2026-03-30 | $2.87M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $2.87M 10-Q · filed 2025-11-14 | $2.87M 10-Q · filed 2025-11-14 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $1.74M derived: sum of 2 quarters · filed 2025-04-15 | $1.74M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $1.74M 10-Q · filed 2024-11-12 | $1.74M 10-Q · filed 2024-11-12 | ||
| 2021-12-31 | $351.39K 10-K · filed 2023-03-31 | |||
| 2021-06-30 | $351.39K 10-Q · filed 2022-11-14 | |||
| 2017-12-31 | $431.57K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |